NM_000093.5:c.925-43G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.925-43G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,605,376 control chromosomes in the GnomAD database, including 162,136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13278 hom., cov: 34)
Exomes 𝑓: 0.45 ( 148858 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.73

Publications

6 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 9-134730193-G-A is Benign according to our data. Variant chr9-134730193-G-A is described in ClinVar as [Benign]. Clinvar id is 255101.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.564 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.925-43G>A intron_variant Intron 6 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.925-43G>A intron_variant Intron 6 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.925-43G>A intron_variant Intron 6 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.925-43G>A intron_variant Intron 6 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.925-43G>A intron_variant Intron 6 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
60611
AN:
151732
Hom.:
13261
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.220
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.573
Gnomad ASJ
AF:
0.619
Gnomad EAS
AF:
0.480
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.461
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.437
Gnomad OTH
AF:
0.450
GnomAD2 exomes
AF:
0.478
AC:
117329
AN:
245350
AF XY:
0.475
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.707
Gnomad ASJ exome
AF:
0.622
Gnomad EAS exome
AF:
0.466
Gnomad FIN exome
AF:
0.464
Gnomad NFE exome
AF:
0.441
Gnomad OTH exome
AF:
0.487
GnomAD4 exome
AF:
0.447
AC:
649937
AN:
1453526
Hom.:
148858
Cov.:
43
AF XY:
0.448
AC XY:
324079
AN XY:
723354
show subpopulations
African (AFR)
AF:
0.207
AC:
6911
AN:
33412
American (AMR)
AF:
0.693
AC:
30973
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.624
AC:
16304
AN:
26112
East Asian (EAS)
AF:
0.471
AC:
18686
AN:
39682
South Asian (SAS)
AF:
0.468
AC:
40321
AN:
86138
European-Finnish (FIN)
AF:
0.462
AC:
22490
AN:
48654
Middle Eastern (MID)
AF:
0.497
AC:
2580
AN:
5196
European-Non Finnish (NFE)
AF:
0.437
AC:
484408
AN:
1109484
Other (OTH)
AF:
0.453
AC:
27264
AN:
60160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
17889
35777
53666
71554
89443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14756
29512
44268
59024
73780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.399
AC:
60663
AN:
151850
Hom.:
13278
Cov.:
34
AF XY:
0.407
AC XY:
30225
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.221
AC:
9155
AN:
41496
American (AMR)
AF:
0.574
AC:
8751
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.619
AC:
2143
AN:
3460
East Asian (EAS)
AF:
0.480
AC:
2461
AN:
5130
South Asian (SAS)
AF:
0.463
AC:
2232
AN:
4818
European-Finnish (FIN)
AF:
0.461
AC:
4850
AN:
10532
Middle Eastern (MID)
AF:
0.452
AC:
132
AN:
292
European-Non Finnish (NFE)
AF:
0.437
AC:
29681
AN:
67864
Other (OTH)
AF:
0.453
AC:
958
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1811
3623
5434
7246
9057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.433
Hom.:
2866
Bravo
AF:
0.402
Asia WGS
AF:
0.506
AC:
1756
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.10
DANN
Benign
0.65
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3128598; hg19: chr9-137622039; COSMIC: COSV65673422; COSMIC: COSV65673422; API